Trends in hospital acquired New Delhi metallo-beta-lactamase-producing Enterobacterales in Tuscany (Italy) from 2019 to 2021: impact of the COVID-19 pandemic.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 13 11 2022
revised: 26 04 2023
accepted: 27 04 2023
medline: 20 6 2023
pubmed: 10 5 2023
entrez: 9 5 2023
Statut: ppublish

Résumé

In Tuscany, Italy, New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE) in hospitalized patients has increasingly been observed since 2018, leading in 2019 to the implementation of enhanced control measures successfully reducing transmission. We describe the NDM-CRE epidemiology during the COVID-19 pandemic in Tuscany. Data on NDM-CRE patients hospitalized in five Tuscan hospitals were collected from January 2019 to December 2021. Weekly rates of NDM-CRE cases on hospital days in medical and critical-care wards were calculated. In March-December 2020, NDM-CRE rates were stratified by COVID-19 diagnosis. Multi-variate regression analysis was performed to assess outcomes' differences among two periods analysed and between COVID-19 populations. Since March 2020, an increase in NDM-CRE cases was observed, associated with COVID-19 admissions. COVID-19 patients differed significantly from non-COVID-19 ones by several variables, including patient features (age, Charlson index) and clinical history and outcomes (NDM-CRE infection/colonization, intensive care unit stay, length of stay, mortality). During the pandemic, we observed a higher rate of NDM-CRE cases per hospital day in both non-COVID-19 patients (273/100,000) and COVID-19 patients (370/100,00) when compared with pre-pandemic period cases (187/100,00). Our data suggest a resurgence in NDM-CRE spread among hospitalized patients in Tuscany during the COVID-19 pandemic, as well as a change in patients' case-mix. The observed increase in hospital transmission of NDM-CRE could be related to changes in infection prevention and control procedures, aimed mainly at COVID-19 management, leading to new challenges in hospital preparedness and crisis management planning.

Identifiants

pubmed: 37160231
pii: S0195-6701(23)00142-1
doi: 10.1016/j.jhin.2023.04.016
pii:
doi:

Substances chimiques

beta-lactamase NDM-1 EC 3.5.2.6
beta-Lactamases EC 3.5.2.6
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-53

Informations de copyright

Copyright © 2023 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Auteurs

G Arzilli (G)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

S Forni (S)

Regional Health Agency of Tuscany, Florence, Italy.

L Righi (L)

Quality of Care and Clinical Networks, Tuscany Region, Florence, Italy.

S Barnini (S)

Microbiology Unit, University Hospital of Pisa, Pisa, Italy.

P Petricci (P)

Laboratory Medicine Unit, Hospital of Leghorn, Leghorn, Italy.

E M Parisio (EM)

Microbiology Unit, San Donato Hospital, Arezzo, Italy.

M Pistello (M)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; Virology Unit, University Hospital of Pisa, Pisa, Italy.

P Vivani (P)

Massa Carrara Hospital, Toscana Northwest Health Authority, Massa Carrara, Italy.

G Gemignani (G)

University Hospital of Pisa, Pisa, Italy.

A Baggiani (A)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; University Hospital of Pisa, Pisa, Italy.

T Bellandi (T)

Centre for Clinical Risk Management and Patient Safety, Florence, Italy.

G Privitera (G)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; University Hospital of Pisa, Pisa, Italy.

F Gemmi (F)

Regional Health Agency of Tuscany, Florence, Italy.

L Tavoschi (L)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Electronic address: lara.tavoschi@unipi.it.

A Porretta (A)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; University Hospital of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH